Respiratory Syncytial Virus among Hospitalised Children in an Era of Pneumococcal Vaccination

Main Article Content

Sara Chandy, PhD Anand Manoharan, PhD., MPH. MS Ramya, MBBS DNB T. Subramanian, MSc Sundaram Balasubramanian, MD

Abstract

Background: Acute respiratory tract infection (ARTI) is the leading cause of paediatric hospitalisations in India, especially ≤5 years of age.


Aim: The study attempts to investigate RSV disease burden in the under-five and any association between NP carriage and viral ARTI.


Methods: This study was conducted from 2019-2020 in Chennai (South India) on hospitalised children with ARTI, between 1 to 60 months of age. Multiplex real-time PCR was employed on nasopharyngeal (NP) samples (n=256) for respiratory pathogens including respiratory syncytial virus (RSV) and Streptococcus pneumoniae (SPN).


Results:). Viral and RSV positivity was 81% and 48.6% respectively. Viral co-infections were evidenced in about a quarter of RSV positive children, common being human parechovirus with RSV. Fever, high respiratory rate, severe respiratory distress, cough, difficulty in breathing, chest indrawing and bronchiolitis were significant clinical findings in paediatric viral ARTI. Pneumococcal conjugate vaccine uptake was high (89.4%) in subjects yet 31.87% of vaccinated children had NP pneumococcal carriage. 75% of those with SPN carriage had viral ARTI of which 35.6% were RSV positive. We observed statistically significant association between NP carriage and viral ARTI (p<0.05). Antibiotic usage in suspected RSV versus non-RSV viral ARTI was 68% and 93.8% respectively.


Conclusion: Significant RSV disease burden in children < 5 years of age, with ARTI is evidenced with a positive association between SPN carriage and viral acute respiratory tract infections. 

Keywords: RSV, Paediatric ARTI, Multiplex real time PCR

Article Details

How to Cite
CHANDY, Sara et al. Respiratory Syncytial Virus among Hospitalised Children in an Era of Pneumococcal Vaccination. Medical Research Archives, [S.l.], v. 11, n. 2, feb. 2023. ISSN 2375-1924. Available at: <https://esmed.org/MRA/mra/article/view/3340>. Date accessed: 21 nov. 2024. doi: https://doi.org/10.18103/mra.v11i2.3340.
Section
Research Articles

References

1. Aberle JH, Aberle SW, Pracher E, Hutter HP, Kundi M, Popow-Kraupp T. Single versus dual respiratory virus infections in hospitalized infants: impact on clinical course of disease and interferon-gamma response. Pediatr Infect Dis J. 2005;24(7):605-610. doi:10.1097/01.inf.0000168741.59747.2
2. Bharaj P, Sullender WM, Kabra SK, et al. Respiratory viral infections detected by multiplex PCR among pediatric patients with lower respiratory tract infections seen at an urban hospital in Delhi from 2005 to 2007. Virol J. 2009;6:89. Published 2009 Jun 26. doi:10.1186/1743-422X-6-89
3. Bont L, Checchia PA, Fauroux B, et al. Defining the Epidemiology and Burden of Severe Respiratory Syncytial Virus Infection Among Infants and Children in Western Countries. Infect Dis Ther. 2016;5(3):271-298. doi:10.1007/s40121-016-0123-0
4. Brand HK, de Groot R, Galama JM, et al. Infection with multiple viruses is not associated with increased disease severity in children with bronchiolitis. Pediatr Pulmonol. 2012;47(4):393-400. doi:10.1002/ppul.21552
5. Broor S, Parveen S, Maheshwari M. Respiratory syncytial virus infections in India: Epidemiology and need for vaccine. Indian J Med Microbiol. 2018;36(4):458-464. doi:10.4103/ijmm.IJMM_19_5
6. Choudhary ML, Anand SP, Wadhwa BS, Chadha MS. Genetic variability of human respiratory syncytial virus in Pune, Western India. Infect Genet Evol. 2013;20:369-377. doi:10.1016/j.meegid.2013.09.025
7. Dagan R, Sikuler-Cohen M, Zamir O, Janco J, Givon-Lavi N, Fraser D. Effect of a conjugate pneumococcal vaccine on the occurrence of respiratory infections and antibiotic use in day-care center attendees. Pediatr Infect Dis J. 2001;20(10):951-958. doi:10.1097/00006454-200110000-00008
8. Griffiths C, Drews SJ, Marchant DJ. Respiratory Syncytial Virus: Infection, Detection, and New Options for Prevention and Treatment. Clin Microbiol Rev. 2017;30(1):277-319. doi:10.1128/CMR.00010-16
9. Kini S, Kalal BS, Chandy S, Shamsundar R, Shet A. Prevalence of respiratory syncytial virus infection among children hospitalized with acute lower respiratory tract infections in Southern India. World J Clin Pediatr. 2019;8(2):33-42. Published 2019 Apr 9. doi:10.5409/wjcp.v8.i2.33
10. Madhi SA, Klugman KP; Vaccine Trialist Group. A role for Streptococcus pneumoniae in virus-associated pneumonia. Nat Med. 2004;10(8):811-813. doi:10.1038/nm1077
11. Mazumdar J, Chawla-Sarkar M, Rajendran K, et al. Burden of respiratory tract infections among paediatric in and out-patient units during 2010-11. Eur Rev Med Pharmacol Sci. 2013;17(6):802-808.
12. Melero JA, García-Barreno B, Martínez I, Pringle CR, Cane PA. Antigenic structure, evolution and immunobiology of human respiratory syncytial virus attachment (G) protein. J Gen Virol. 1997;78 ( Pt 10):2411-2418. doi:10.1099/0022-1317-78-10-2411
13. Mishra P, Nayak L, Das RR, Dwibedi B, Singh A. Viral Agents Causing Acute Respiratory Infections in Children under Five: A Study from Eastern India. Int J Pediatr. 2016;2016:7235482. doi:10.1155/2016/7235482
14. Morpeth SC, Munywoki P, Hammitt LL, et al. Impact of viral upper respiratory tract infection on the concentration of nasopharyngeal pneumococcal carriage among Kenyan children. Sci Rep. 2018;8(1):11030. Published 2018 Jul 23. doi:10.1038/s41598-018-29119-w
15. Nair H, Nokes DJ, Gessner BD, et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet. 2010;375(9725):1545-1555. doi:10.1016/S0140-6736(10)60206-1.
16. Pneumonia Etiology Research for Child Health (PERCH) Study Group. Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: the PERCH multi-country case-control study [published correction appears in Lancet. 2019 Aug 31;394(10200):736]. Lancet. 2019;394(10200):757-779. doi:10.1016/S0140-6736(19)30721-4
17. Saxena S, Tripathi R, Kushwaha RAS, Kumari R, Bhattacharya P and Dhole TN: Comparison of conventional and real time PCR for monitoring of respiratory syncytial virus among pediatric patients in Northern India 2011-2014. Int J Pharm Sci & Res 2019; 10(5): 2294- 00. doi: 10.13040/IJPSR.0975-8232.10(5).2294-00.
18. Shi T, McAllister DA, O'Brien KL, et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study. Lancet. 2017;390(10098):946-958. doi:10.1016/S0140-6736(17)30938-8
19. Swamy MA, Malhotra B, Reddy PV, Tiwari JK, Kumar N, Gupta ML. Trends of respiratory syncytial virus sub-types in children hospitalised at a tertiary care centre in Jaipur during 2012-2014. Indian J Med Microbiol. 2017;35(1):134-136. doi:10.4103/ijmm.IJMM_15_306
20. Zar HJ, Polack FP. Childhood pneumonia: the role of viruses. Thorax. 2015;70(9):811-812. doi:10.1136/thoraxjnl-2015-207320